of San Francisco
Understanding Proliferative Diabetic Retinopathy: A San Francisco Perspective
| Premier Eyecare San Francisco
Welcome to Premier Eyecare, your trusted source for comprehensive eye care in San Francisco, CA. At our practice, we are committed to educating our community about eye health, and today, we're shedding light on a critical issue - proliferative diabetic retinopathy. This blog aims to raise awareness about this condition while offering valuable insights into its causes, symptoms, and treatment options.
What Is Proliferative Diabetic Retinopathy?
Proliferative diabetic retinopathy (PDR) is a serious eye condition that can affect individuals with diabetes. It occurs when high blood sugar levels damage the blood vessels in the retina, the light-sensitive tissue at the back of the eye. Over time, these damaged vessels can trigger abnormal growth of new blood vessels, which is where the term "proliferative" comes from.
Understanding the Stages:
PDR typically progresses through various stages:
Symptoms:
PDR may not exhibit noticeable symptoms in its early stages, and vision may seem normal, which is why regular eye exams are crucial for individuals with diabetes. As the condition progresses, symptoms may include:
Diagnosis:
Early detection of PDR is essential. At Premier Eyecare, our experienced ophthalmologists and optometrists utilize advanced diagnostic tools, such as OCT scanning and ultra-widefield retinal imaging, to identify diabetic retinopathy and monitor its progression.
Treatment Options:
The management of PDR depends on its severity:
Diabetes is the leading cause of legal blindness in working-age Americans. Proliferative diabetic retinopathy is a serious complication of diabetes that can lead to vision loss if left untreated. Regular eye exams at Premier Eyecare can help catch this condition in its early stages when it's most manageable. If you or a loved one have diabetes, don't hesitate to schedule an appointment with our skilled ophthalmologists and optometrists in San Francisco, CA.